OLIG2 and glioblastoma: Although our study employed patient-derived glioblastoma stem cells and relied on functional assays to assess treatment impact, future studies incorporating flow cytometry-based analysis of stemness markers (e.g., Olig2, Sox2, Nestin) will be important to further characterize phenotypic shifts induced by FGFR inhibition and radiation.